Literature DB >> 27868026

Preclinical randomized controlled multicenter trials in translational stroke research.

Sergio Amaro1, Laura Llull1.   

Abstract

Entities:  

Year:  2016        PMID： 27868026      PMCID： PMC5104619          DOI： 10.21037/atm.2016.10.66

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  9 in total

Review 1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

2.  International, multicenter randomized preclinical trials in translational stroke research: it's time to act.

Authors:  Ulrich Dirnagl; Marc Fisher
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-18       Impact factor: 6.200

Review 3.  Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review.

Authors:  Amy C Plint; David Moher; Andra Morrison; Kenneth Schulz; Douglas G Altman; Catherine Hill; Isabelle Gaboury
Journal:  Med J Aust       Date:  2006-09-04       Impact factor: 7.738

4.  Thomas Willis Lecture: Is Translational Stroke Research Broken, and if So, How Can We Fix It?

Authors:  Ulrich Dirnagl
Journal:  Stroke       Date:  2016-06-28       Impact factor: 7.914

Review 5.  Clinical Trials of Immunomodulation in Ischemic Stroke.

Authors:  Roland Veltkamp; Dipender Gill
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

6.  Translational stroke research of the combination of thrombolysis and antioxidant therapy.

Authors:  Sergio Amaro; Ángel Chamorro
Journal:  Stroke       Date:  2011-04-07       Impact factor: 7.914

Review 7.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  Carol Kilkenny; William J Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

Review 8.  Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation.

Authors:  Ángel Chamorro; Ulrich Dirnagl; Xabier Urra; Anna M Planas
Journal:  Lancet Neurol       Date:  2016-05-11       Impact factor: 44.182

9.  Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia.

Authors:  Gemma Llovera; Kerstin Hofmann; Stefan Roth; Angelica Salas-Pérdomo; Maura Ferrer-Ferrer; Carlo Perego; Elisa R Zanier; Uta Mamrak; Andre Rex; Hélène Party; Véronique Agin; Claudine Fauchon; Cyrille Orset; Benoît Haelewyn; Maria-Grazia De Simoni; Ulrich Dirnagl; Ulrike Grittner; Anna M Planas; Nikolaus Plesnila; Denis Vivien; Arthur Liesz
Journal:  Sci Transl Med       Date:  2015-08-05       Impact factor: 17.956
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.